Table 4.
Raw Scores at Baseline and 13 week (end of treatment) in selected outcome vari
| Variable | Treatment Group |
N | Baseline | Week 13 | Change |
|---|---|---|---|---|---|
| PASa Total | NMES | 90 | 5.13 (1.88) | 5.14 (1.84) | 0.01 (1.04) |
| Sham | 35 | 5.48 (1.66) | 4.91 (2.11) | −0.57 (1.62) | |
| OPSEb | NMES | 81 | 41.47 (20.98) | 41.81 (20.1) | 0.34 (14.75) |
| Sham | 30 | 35.88 (19.93) | 40.72 (19.74) | 4.84 (17.44) | |
| Hyoid Anterior Total | NMES | 76 | 7.05 (4.07) | 6.42 (4.47) | −0.62 (3.49) |
| Sham | 32 | 6.57 (3.4) | 5.86 (3.24) | −0.71 (2.47) | |
| Hyoid Superior Total | NMES | 76 | 16.81 (9.16) | 15.94 (7.87) | −0.87 (6.72) |
| Sham | 32 | 16.91 (7.82) | 17.31 (8.85) | 0.4 (5.58) | |
| % Residue in Pharynx | Sham | 85 | 30.81 (15.65) | 30.55 (17.24) | −0.26 (10.02) |
| NMES | 34 | 35.84 (19.58) | 31.74 (16.31) | −4.1 (18.26) | |
| PSSc Total | NMES | 91 | 60.73 (22.11) | 66.98 (21.55) | 6.25 (14.45) |
| Sham | 35 | 58.38 (20.36) | 62.9 (21.31) | 4.52 (16.06) | |
| HNCId Eating | NMES | 86 | 32.54 (21.04) | 38.85 (23.97) | 6.31 (17.92) |
| Sham | 34 | 24.18 (18.58) | 30.93 (20.46) | 6.74 (15.59) |
a
Penetration Aspiration Scale (PAS)
b
Oralpharyngeal Swallowing Efficiency (OPSE)
c
Performance Status Scale (PSS)
d
Head and Neck Cancer Inventory (HNCI)